Client News

Verona Pharma plc: Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2019

Medigene AG: Medigene to present on neoantigens as targets for TCR-T cell-based therapies at 2019 SITC Annual Meeting

ORYX Provides Strategic Update on the Clinical Development of Oncolytic Virotherapy ParvOryx

Atriva Therapeutics to present at the BIO-Europe in Hamburg

ORYX Announces Positive Phase I/IIa Data for Oncolytic Virus ParvOryx Demonstrating Safety, Anti-tumor Effects, Partial Responses and Prolonged Overall Survival in Metastatic, Inoperable Pancreatic Cancer

Medigene AG: Medigene participates at upcoming conferences

Newron Initiates Outreach on First Global Rett Syndrome Burden of Illness Survey in Collaboration with the Rett Community

Expedeon AG raises adjusted EBITDA guidance for 2019

Rentschler Biopharma management duo Nikolaus F. Rentschler and Frank Mathias recognized as “EY Entrepreneur of the Year”

Motif Bio plc: U.S. Army-funded research project to Evaluate Iclaprim